Market Value176,720,000
Total Holdings51
File Date2016-05-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Note this is an amended filing that contain additional holdings that were omitted from a previous filing. This is not likely to be an accurate picture of the total holdings of this firm.

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AGIO / Agios Pharmaceuticals, Inc.
ACAD / ACADIA Pharmaceuticals Inc. Put
ACAD / ACADIA Pharmaceuticals Inc.
IHF / iShares Trust - iShares U.S. Healthcare Providers ETF
CYNA / Cynapsus Therapeutics Inc.
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Call
ARCT / Arcturus Therapeutics Holdings Inc.
IHI / iShares Trust - iShares U.S. Medical Devices ETF
VTAE / Vitae Pharmaceuticals, Inc.
STJ / St. Jude Medical, Inc.
EW / Edwards Lifesciences Corporation Call
BSX / Boston Scientific Corporation
ENDP / Endo International plc
US16706W1027 / Chiasma Inc
NSTG / NanoString Technologies, Inc.
IHE / iShares Trust - iShares U.S. Pharmaceuticals ETF
US00448Q2012 / Achillion Pharmaceuticals, Inc.
US3723091043 / GenMark Diagnostics, Inc
OCRX / Ocera Therapeutics, Inc.
NUVA / Nuvasive Inc
VCYT / Veracyte, Inc.
SBBP / Strongbridge Biopharma plc
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
IART / Integra LifeSciences Holdings Corporation
BMRN / BioMarin Pharmaceutical Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
91911K102 / Bausch Health Companies Call
ENTL / Entellus Medical, Inc.
PACB / Pacific Biosciences of California, Inc.
98235T107 / Wright Medical Group N.V.
CLVS / Clovis Oncology Inc
RMD / ResMed Inc.
SPNC / Spectranetics Corp. (The)
HZNP / Horizon Therapeutics Plc
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
VRTX / Vertex Pharmaceuticals Incorporated
0PP / Portola Pharmaceuticals Inc
0PP / Portola Pharmaceuticals Inc Call
IWM / iShares Trust - iShares Russell 2000 ETF Put
ABBV / AbbVie Inc. Call
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
MDT / Medtronic plc
ISEE / IVERIC bio Inc
IOVA / Iovance Biotherapeutics, Inc.
TNDM / Tandem Diabetes Care, Inc.
CELG / Celgene Corp.
HRTX / Heron Therapeutics, Inc.
NVRO / Nevro Corp.
SAGE / Sage Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.